Population
Cardiac myocytes
Comparison
Adenovirus E1A oncoproteins vs Control
Design
Preclinical
Authors
Loading...
May limit E1A-based vectors for cardiac gene delivery; leaves open distinct mechanisms for myocyte-specific promoters.
Adenovirus E1A inhibits cardiac-specific gene expression via its amino-terminal domain, utilizing a distinct mechanism from general promoter inhibition.
Bishopric et al. (1997) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: